Morrisville, North Carolina -- Biotechnology sensor company Centice has received $1.8 million in venture capital debt investment, according to an SEC regulatory filing.
Centice manufactures molecular spectroscopic optical sensors for a variety of general purpose and application-specific biotech products.
Investors in the financing were not disclosed nor was how the company intends to use the funding proceeds.
Centice is still seeking $835,000 in additional debt financing, according to the filing. |